03/12/2025
3:30 PM | Castle Biosciences (Issuer)
Cotton Rodney (Reporting)
| Form 4/A | |
03/06/2025
3:10 PM | Castle Biosciences (Issuer)
Stokes Frank (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
4:28 PM | Castle Biosciences (Subject)
MAETZOLD DEREK J (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/27/2025
3:10 PM | Castle Biosciences (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/27/2025
3:13 PM | Castle Biosciences (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/24/2025
3:23 PM | Castle Biosciences (Issuer)
Stokes Frank (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2025
3:25 PM | BRADBURY DANIEL (Reporting)
Castle Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/30/2025
8:33 PM | Castle Biosciences (Subject)
VANGUARD GROUP INC (Filed by)
| Form SCHEDULE 13G/A | |
01/15/2025
3:57 PM | Castle Biosciences (Issuer)
MAETZOLD DEREK J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/13/2025
5:58 AM | Castle Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/08/2025
5:19 PM | BRADBURY DANIEL (Reporting)
Castle Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for CSTL and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Castle Biosciences and its competitors with MarketBeat's FREE daily newsletter. |
01/08/2025
5:17 PM | Castle Biosciences (Issuer)
Juvenal Tobin W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2025
5:18 PM | Castle Biosciences (Issuer)
MAETZOLD DEREK J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/19/2024
3:39 PM | Castle Biosciences (Issuer)
MAETZOLD DEREK J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/17/2024
3:21 PM | Castle Biosciences (Issuer)
MAETZOLD DEREK J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/13/2024
4:00 PM | Castle Biosciences (Subject)
MAETZOLD DEREK J (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/11/2024
3:55 PM | Castle Biosciences (Issuer)
Juvenal Tobin W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/09/2024
4:09 PM | Castle Biosciences (Issuer)
MAETZOLD DEREK J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/05/2024
3:28 PM | BRADBURY DANIEL (Reporting)
Castle Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/03/2024
4:14 PM | BRADBURY DANIEL (Reporting)
Castle Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/14/2024
5:21 PM | Castle Biosciences (Issuer)
MAETZOLD DEREK J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/13/2024
5:44 PM | Castle Biosciences (Subject)
WASATCH ADVISORS LP (Filed by)
| Form SC 13G/A | |
11/06/2024
3:21 PM | Castle Biosciences (Issuer)
MAETZOLD DEREK J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/05/2024
3:32 PM | BRADBURY DANIEL (Reporting)
Castle Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/05/2024
3:33 PM | Castle Biosciences (Issuer)
Juvenal Tobin W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/04/2024
4:34 PM | Castle Biosciences (Subject)
MAETZOLD DEREK J (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/01/2024
3:49 PM | Castle Biosciences (Subject)
Juvenal Tobin W (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/16/2024
3:34 PM | Castle Biosciences (Issuer)
MAETZOLD DEREK J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/10/2024
3:22 PM | Castle Biosciences (Issuer)
MAETZOLD DEREK J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/09/2024
3:30 PM | BRADBURY DANIEL (Reporting)
Castle Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/08/2024
3:48 PM | Castle Biosciences (Issuer)
MAETZOLD DEREK J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/07/2024
4:33 PM | BRADBURY DANIEL (Reporting)
Castle Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/18/2024
3:23 PM | Castle Biosciences (Issuer)
MAETZOLD DEREK J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/13/2024
3:33 PM | Castle Biosciences (Issuer)
MAETZOLD DEREK J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/11/2024
3:15 PM | Castle Biosciences (Issuer)
MAETZOLD DEREK J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/09/2024
4:18 PM | Castle Biosciences (Subject)
MAETZOLD DEREK J (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/05/2024
3:06 PM | Castle Biosciences (Issuer)
Oelschlager Kristen M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/05/2024
3:07 PM | Castle Biosciences (Issuer)
MAETZOLD DEREK J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/27/2024
3:11 PM | Castle Biosciences (Issuer)
MAETZOLD DEREK J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/23/2024
4:17 PM | Castle Biosciences (Subject)
MAETZOLD DEREK J (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/13/2024
5:13 PM | Castle Biosciences (Issuer)
Stokes Frank (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Musk’s real agenda in D.C. (Ad) In this urgent exposé, you’ll discover…
How Elon and Donald Trump are quietly drawing a radical new map of America… Here’s the full story. |
08/13/2024
5:14 PM | Castle Biosciences (Issuer)
Stokes Frank (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/13/2024
5:15 PM | Castle Biosciences (Issuer)
Oelschlager Kristen M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/13/2024
5:16 PM | Castle Biosciences (Issuer)
Juvenal Tobin W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/13/2024
5:17 PM | Castle Biosciences (Issuer)
MAETZOLD DEREK J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/12/2024
3:37 PM | BRADBURY DANIEL (Reporting)
Castle Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/02/2024
2:13 PM | Castle Biosciences (Subject)
Stokes Frank (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/16/2024
5:43 PM | BRADBURY DANIEL (Reporting)
Castle Biosciences (Issuer)
| Form 4/A | |
07/16/2024
3:49 PM | Castle Biosciences (Issuer)
Goldberg Ellen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/16/2024
3:51 PM | Caple Kim (Reporting)
Castle Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/08/2024
3:32 PM | BlackRock Inc. (Filed by)
Castle Biosciences (Subject)
| Form SC 13G/A | |
07/01/2024
3:45 PM | Castle Biosciences (Subject)
Oelschlager Kristen M (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/05/2024
4:23 PM | Castle Biosciences (Issuer)
MAETZOLD DEREK J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2024
5:52 PM | Aspinall Mara G. (Reporting)
Castle Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/03/2024
4:21 PM | Castle Biosciences (Subject)
MAETZOLD DEREK J (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/29/2024
3:40 PM | Castle Biosciences (Issuer)
Harrison Miles (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/29/2024
3:41 PM | Castle Biosciences (Issuer)
Goldberg Ellen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/29/2024
3:43 PM | Castle Biosciences (Issuer)
Cole G Bradley (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/29/2024
3:44 PM | Caple Kim (Reporting)
Castle Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/29/2024
3:46 PM | BRADBURY DANIEL (Reporting)
Castle Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/29/2024
3:37 PM | Castle Biosciences (Issuer)
Olson Tiffany (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/28/2024
3:18 PM | Castle Biosciences (Issuer)
Cotton Rodney (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/28/2024
3:10 PM | Castle Biosciences (Issuer)
Olson Tiffany (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/28/2024
3:13 PM | Castle Biosciences (Issuer)
Goldberg Ellen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/28/2024
3:15 PM | Caple Kim (Reporting)
Castle Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/28/2024
3:05 PM | BRADBURY DANIEL (Reporting)
Castle Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/28/2024
3:06 PM | Castle Biosciences (Issuer)
Cole G Bradley (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/28/2024
3:08 PM | Castle Biosciences (Issuer)
Harrison Miles (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/10/2024
2:14 PM | Castle Biosciences (Filer)
| Form DEFA14A | |
05/08/2024
3:47 PM | Castle Biosciences (Issuer)
MAETZOLD DEREK J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/08/2024
3:51 PM | BRADBURY DANIEL (Reporting)
Castle Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/02/2024
3:15 PM | Castle Biosciences (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/25/2024
3:54 PM | Castle Biosciences (Issuer)
MAETZOLD DEREK J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/16/2024
11:15 PM | Castle Biosciences (Filer)
| Form EFFECT | |
04/16/2024
3:46 PM | Castle Biosciences (Issuer)
MAETZOLD DEREK J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/12/2024
3:36 PM | Castle Biosciences (Subject)
MAETZOLD DEREK J (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/10/2024
3:35 PM | BRADBURY DANIEL (Reporting)
Castle Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/10/2024
3:05 PM | Castle Biosciences (Filer)
| Form DEF 14A | |
04/10/2024
3:07 PM | Castle Biosciences (Filer)
| Form DEFA14A | |
04/10/2024
3:08 PM | Castle Biosciences (Filer)
| Form ARS | |
04/08/2024
3:31 PM | BRADBURY DANIEL (Reporting)
Castle Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/05/2024
3:37 PM | Castle Biosciences (Issuer)
MAETZOLD DEREK J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/04/2024
4:02 PM | BRADBURY DANIEL (Reporting)
Castle Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/28/2024
3:43 PM | Castle Biosciences (Issuer)
Cotton Rodney (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/28/2024
3:30 PM | Castle Biosciences (Issuer)
Cotton Rodney (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
